CJC-1295 with DAC is a synthetic peptide belonging to the group of growth hormone–releasing hormone (GHRH) analogues and is the subject of scientific and preclinical research. Due to the presence of the so-called Drug Affinity Complex (DAC), it binds to plasma proteins in the body, which significantly prolongs its biological activity compared to classical GHRH peptides. This property makes it an interesting research molecule for studying long-term hormonal regulation.
Research studies primarily focus on its ability to stimulate the natural release of growth hormone from the pituitary gland in a pulsatile manner that mimics the body’s physiological processes. In preclinical models, CJC-1295 with DAC is associated with tissue repair and regeneration processes, support of muscle mass growth, and regulation of metabolic functions. Particular attention is also given to its effects on IGF-1 levels, which play an important role in growth and regenerative mechanisms.
Further research examines the effects of CJC-1295 with DAC in relation to sleep quality, energy balance, and the body’s adaptation to physical stress, as growth hormone is closely linked to these processes. Owing to its prolonged duration of action and relatively stable activity profile, CJC-1295 with DAC is primarily used as a research tool for more detailed study of the long-term effects of growth hormone and its role in regulating biological processes in the body.
